Literature DB >> 15965183

"Ecstasy" induced immunosuppression and herpes zoster ophthalmicus.

O M Zwick, D H Fischer, J C Flanagan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15965183      PMCID： PMC1772719          DOI： 10.1136/bjo.2004.061150

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  10 in total

1.  Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans.

Authors:  R Pacifici; P Zuccaro; C Hernandez López; S Pichini; S Di Carlo; M Farré; P N Roset; J Ortuño; J Segura; R L Torre
Journal:  J Pharmacol Exp Ther       Date:  2001-01       Impact factor: 4.030

Review 2.  MDMA ('ecstasy') and other 'club drugs'. The new epidemic.

Authors:  Stephen C Koesters; Peter D Rogers; Christiana R Rajasingham
Journal:  Pediatr Clin North Am       Date:  2002-04       Impact factor: 3.278

3.  Ecstasy induced acute myocardial infarction.

Authors:  A Qasim; J Townend; M K Davies
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

Review 4.  Clinical practice. Herpes zoster.

Authors:  John W Gnann; Richard J Whitley
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

5.  Aortic dissection after ingestion of "ecstasy" (MDMA).

Authors:  J Duflou; A Mark
Journal:  Am J Forensic Med Pathol       Date:  2000-09       Impact factor: 0.921

6.  An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats.

Authors:  T J Connor; J P Kelly; B E Leonard
Journal:  Immunopharmacology       Date:  2000-03

Review 7.  Agony and ecstasy: a review of MDMA effects and toxicity.

Authors:  C Burgess; A O'Donohoe; M Gill
Journal:  Eur Psychiatry       Date:  2000-08       Impact factor: 5.361

8.  Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces a rapid and sustained suppression of immune function in the rat.

Authors:  T J Connor; M G McNamara; D Finn; A Currid; M O'Malley; A M Redmond; J P Kelly; B E Leonard
Journal:  Immunopharmacology       Date:  1998-01

Review 9.  Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system.

Authors:  Thomas J Connor
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

10.  Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus.

Authors:  S J Peroutka
Journal:  N Engl J Med       Date:  1987-12-10       Impact factor: 91.245
  10 in total
  2 in total

1.  3,4-Methylenedioxymethamphetamine (MDMA) alters acute gammaherpesvirus burden and limits interleukin 27 responses in a mouse model of viral infection.

Authors:  Daniel A Nelson; Sam J Singh; Amy B Young; Melanie D Tolbert; Kenneth L Bost
Journal:  Drug Alcohol Depend       Date:  2011-01-26       Impact factor: 4.492

Review 2.  Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?

Authors:  Noreen T Boyle; Thomas J Connor
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.